
What We’re Reading: ND Supreme Court Blocks Abortion Ban; Paxlovid and COVID-19; Sanofi Joins Insulin Price Cuts
The high court in North Dakota voted to protect abortion in that state; an outside panel of FDA expert advisors voted to support a full approval for Paxlovid; Sanofi follows competitors' price caps for insulin.
North Dakota Supreme Court Blocks State’s Abortion Ban
In a majority ruling, North Dakota’s Supreme Court backed a lower court’s decision to block a state-wide abortion ban, according to
FDA Advisors Approve Paxlovid for Treating COVID-19 in High-Risk Adults
The US Food and Drug Administration (FDA) voted 16-1 supporting the full approval of Paxlovid as a treatment of mild and moderate COVID-19 in high-risk adults, according to
Sanofi Follows After Eli Lilly and Novo Nordisk with Insulin Price Cap
Sanofi announced that it will cap out-of-pocket costs at $35 for its most popular insulin drug, Lantus [insulin glargine (rDNA origin) injection], according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.